3D quantitative analysis of diffusion-weighted imaging for predicting the malignant potential of intraductal papillary mucinous neoplasms of the pancreas by Igarashi, Takao et al.
e298
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 
International (CC BY-NC-ND 4.0). License (https://creativecommons.org/licenses/by-nc-nd/4.0/). 






3D quantitative analysis of diffusion-weighted imaging for predicting 
the malignant potential of intraductal papillary mucinous neoplasms 
of the pancreas
Takao IgarashiA,B,C,D,E,F, Megumi ShiraishiB, Ken WatanabeB, Kazuyoshi OhkiD, Shinsuke TakenagaE,  
Hirokazu AshidaE, Hiroya OjiriE
Department of Radiology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan
Abstract
Purpose: To investigate the predictors of intraductal papillary mucinous neoplasms of the pancreas (IPMNs) with 
high-grade dysplasia, using 2-dimensional (2D) analysis and 3-dimensional (3D) volume-of-interest-based apparent 
diffusion coefficient (ADC) histogram analysis.
Material and methods: The data of 45 patients with histopathologically confirmed IPMNs with high-grade or low-
grade dysplasia were retrospectively assessed. The 2D analysis included lesion-to-spinal cord signal intensity ratio 
(LSR), minimum ADC value (ADCmin), and mean ADC value (ADCmean). The 3D analysis included the overall mean 
(ADCoverall mean), mean of the bottom 10
th percentile (ADCmean0-10), mean of the bottom 10-25
th percentile (ADCmean10-25), 
mean of the bottom 25-50th percentile (ADCmean25-50), skewness (ADCskewness), kurtosis (ADCkurtosis), and entropy  
(ADCentropy). Diagnostic performance was compared by analysing the area under the receiver operating characteristic 
curve (AUC). Inter-rater reliability was assessed by blinded evaluation using the intraclass correlation coefficient. 
Results: There were 16 and 29 IPMNs with high- and low-grade dysplasia, respectively. The LSR, ADCoverall mean,  
ADCmean0-10, ADCmean10-25, ADCmean25-50, and ADCentropy showed significant between-group differences (AUC = 72-93%; 
p < 0.05). Inter-rater reliability assessment showed almost perfect agreement for LSR and substantial agreement for 
ADCoverall mean and ADCentropy. Multivariate logistic regression showed that ADCoverall mean and ADCentropy were 
significant independent predictors of malignancy (p < 0.05), with diagnostic accuracies of 80% and 73%, respectively.
Conclusion: ADCoverall mean and ADCentropy from 3D analysis may assist in predicting IPMNs with high-grade dysplasia.
Key words: diffusion magnetic resonance imaging, mucinous carcinoma, pancreatic duct, pancreatic intraductal neo-
plasms.
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Introduction
Intraductal papillary mucinous neoplasms of the pancreas 
(IPMNs) were first recognized as an entity in the 1980s 
[1,2] and are increasingly detected due to widespread use 
of imaging technology. IPMNs are classified into those 
with low-grade dysplasia, with high-grade dysplasia, 
and with invasive carcinoma [3]. High-grade IPMNs are 
histopathologically considered as an early cancer stage. 
The 5-year survival rates for non-invasive and invasive 
IPMNs are 88-100% [4,5] and 34-42% [6,7], respectively. 
Thus, high-grade dysplastic IPMNs may be a potentially 
curable pancreatic cancer if treated before becoming inva-
sive. The favourable prognostic factors for IPMN-associ-
ated carcinoma (compared with common-type pancreatic 
ductal carcinoma) are lower rates of advanced T stage dis-
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ease, lymph node metastasis, high tumour grade, positive 
resection margin, and perineural and vascular invasion 
[8]. These factors, associated with imaging findings, can be 
assessed using preoperative magnetic resonance imaging 
(MRI); therefore, MRI findings could be significant for the 
evaluation of the malignant potential of IPMN, particu-
larly prior to progression to invasive carcinoma. Differenti-
ating potentially malignant from benign neoplasms before 
this stage can help guide clinical strategy, in particular if 
a non-invasive screening technique can be used.
MRI with magnetic resonance cholangiopancreato-
graphy (MRCP) is a useful imaging modality for evaluat-
ing the malignant potential and surgical resectability of 
IPMNs [9]. More specifically, diffusion-weighted imaging 
(DWI) is considered effective for the diagnosis of malig-
nant IPMNs [10-12], but with limited evidence. Malignant 
pancreatic tumours generally show higher signal intensities 
on DWI and lower apparent diffusion coefficient (ADC) 
values than do benign tumours [13,14]. DWI performance 
in evaluating the malignant potential of cystic pancreatic le-
sions is comparable to that of contrast-enhanced magnetic 
resonance imaging (MRI) [12,15]. Furthermore, the com-
bined use of DWI and MRCP, and the use of the minimum 
(ADCmin) and mean ADC (ADCmean) values, are effective 
for diagnosing malignant IPMNs and predicting the risk 
for IPMNs with invasive carcinoma [10,12,13]. The lesion-
to-spinal cord signal intensity ratio (LSR) was recently 
proposed as a useful measure for predicting malignancy. 
LSR is a convenient semiquantitative variable that can 
be calculated on DWI [16-19]. LSR is comparable to the 
ADC measurement method and can be used with any MRI 
scanner [17,18]. In general, the conventional method, us-
ing 2-dimensional region-of-interest (ROI)-based analysis 
(hereafter referred to as 2D analysis), may be highly repre-
sentative, is less amenable to manual ROI variability, and 
is less time-consuming. Conversely, whole-lesion ADC-
histogram analysis using 3-dimensional volume-of-interest 
(VOI) (hereafter referred to as 3D analysis) of the entire 
IPMN is also useful for assessing the malignant potential of 
pancreatic IPMNs [20]. Pixel-by-pixel analysis of a slice in 
a tumour can reveal tumour heterogeneity [20]. 
However, the best method for predicting malignant 
potential in early-stage IPMNs remains unclear. More-
over, differentiating IPMNs with high-grade dysplasia 
from those with low-grade dysplasia using non-invasive 
techniques may help optimize clinical strategies. Thus, 
this study investigated the predictors of IPMNs with high-
grade dysplasia using 2D and 3D analyses based on DWI.
Material and methods
Patients
This retrospective study was approved by the relevant 
review committee, and the procedures followed were 
in accordance with the Helsinki Declaration of 1975, as 
revised in 2000. The requirement for written informed 
consent was waived by the relevant institutional review 
board because of the retrospective study design. The study 
included patients who were diagnosed with IPMN of the 
pancreas, with a maximum mass diameter ≥ 1 cm, based 
on post-surgical histopathological reports, between 1 June 
2009 and 30 September 2019. All data were retrospec-
tively identified from our institutional imaging database. 
We excluded patients who did not undergo MRI within 
6 months pre-surgery, in whom IPMN with a maximum 
diameter < 1 cm was an incidental finding (not indicated 
for surgery), and who were histopathologically diagnosed 
with IPMNs with invasive carcinoma. No patient under-
went fine needle aspiration (FNA) or chemotherapy be-
fore MRI and surgery.
Magnetic resonance imaging technique
All patients underwent MRI on a 1.5-Tesla MR unit (Mag-
netom Avanto or Symphony, Siemens Medical Solutions, 
Erlangen, Germany [n = 39]) with a 6-channel body ma-
trix coil, or a 3.0-Tesla MR unit (Skyra, Siemens Medical 
Solutions, Erlangen, Germany [n = 6]) with an 18-channel 
body coil. 
T1-weighted breath-hold spoiled gradient-recalled-
echo (GRE) in-phase and opposed-phase images, 3D-fat-
suppressed T1-weighted GRE sequences with Cartesian 
sampling (volumetric interpolated breath-hold examina-
tion on Siemens Healthcare MRI systems), T2-weighted 
fast-spin-echo images, DW images with low and high 
b-values (b = 50 and 800 s/mm2, respectively), and half-
Fourier acquisition single-shot turbo spin-echo sequences 
were obtained. ADC maps were automatically gener-
ated using the operating console. Respiratory-triggered 
3D-T2-weighted MRCP with maximum intensity projec-
tion was performed. Details of imaging parameters in this 
study are summarized in Supplementary Table 1.
Histopathological analysis
Determination of the IPMN grade (low-grade dysplasia, 
high-grade dysplasia, and invasive carcinoma) was based 
on the highest-grade focus. The presence or absence of 
invasive carcinoma was determined based on histopatho-
logical examinations in all cases. Lesions with minimal 
invasion, i.e. a few lesions with only a few tumour glands 
communicating with the intraductal carcinoma compo-
nents, were also considered invasive carcinoma.
Image analysis
A radiologist (17 years of MRI experience) retrospective-
ly reviewed all MR images. The reader was not blinded 
to preoperative reports of computed tomography, MRI, 
endoscopic ultrasonography, or clinical and histopatho-
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logical examinations. With reference to the revised In-
ternational Consensus Guidelines for the Management 
of IPMN of the Pancreas, 2017 [21], preoperative MRI 
features were evaluated on a picture archiving and com-
munication system (PACS) monitor.
Binary MRI variables were evaluated as present or ab-
sent, as follows: enhancing mural nodule > 5 mm, main 
pancreatic duct (MPD) size ≥ 10 mm, cyst size ≥ 3 cm, 
enhancing mural nodule < 5 mm, thickened enhancing 
cyst wall ≥ 3 mm, MPD size 5-9 mm, abrupt MPD calibre 
change, and lymphadenopathy. An electronic calliper, in-
cluded in the PACS program, was used to obtain measure-
ments from any axial or coronal image. If several cystic 
lesions were present, the lesion with the largest wall and 
septal thickness and mural nodule was used for analysis. 
A mural nodule was defined as any solid nodule in the 
MPD or branch duct of a well-circumscribed tissue lesion 
surrounded by a duct wall. Lymphadenopathy was con-
sidered “present” when the short axis diameter exceeded 
10 mm. 
Blinded evaluation during 2D and 3D analyses
All data except information regarding the target lesion 
were anonymized. One blinded radiologist (Reader 1: 4 
years’ experience) analysed body MR images to determine 
LSR, ADCmin, and ADCmean of all lesions for 2D analysis. 
Figure 1 illustrates the 2D analysis methods used. LSR 
was measured on a DW image with a diffusion gradient 
of b = 800 s/mm2 and calculated as follows: mean signal 
intensity of the lesion on DWI/maximum signal intensity 
of the spinal cord on DWI. ADC values were measured 
after establishing LSR. ROI in the spinal cord on DWI 
was located on a slice of the lumbar enlargement because 
the tissue volume was larger in this area than in other 
spinal regions, thus facilitating ROI localization. ROIs of 
the same size were set at the same location as that of the 
pancreatic lesion on each DW image and ADC map. ROIs 
in the pancreatic lesion on both the DW image and ADC 
map were round or oval and covered the solid compo-
nent or septum/cyst wall as much as possible, excluding 
a partial-volume phenomenon. The highest mean signal 
intensity of the lesion on DWI, the lowest ADCmin, and the 
lowest ADCmean among the 3 measurements were adopted 
for analyses.
The same lesions evaluated by 2D analysis were sub-
jected to 3D analysis by the same radiologist. For each 
patient, a 3D-VOI was placed on the area recognized 
as a mass with solid components on the ADC map us-
ing specialized application software (FireVoxel; https://
wp.nyu.edu/firevoxel). ADC values were constructed into 
a histogram, which was used to obtain parameters of the 
first-order statistical properties of the image. The overall 
mean (ADCoverall mean), mean of the bottom 10
th percen-
tile (ADCmean0-10), mean of the bottom 10-25
th percentile 
(ADCmean10-25), mean of the bottom 25-50
th percen-
tile (ADCmean25-50), skewness (ADCskewness), kurtosis 
(ADCkurtosis), and entropy (ADCentropy) [22] were deter-
mined. Figure 2 illustrates the 3D analysis methods used. 
To investigate the reproducibility of the results of Reader 1, 
another blinded radiologist (Reader 2: 12 years’ expe-
rience) performed 2D and 3D analyses using the same 
Table 1. Clinical characteristics of patients in our cohort
Factor IPMNs with high-grade dysplasia 
n = 16
IPMNs with low-grade dysplasia 
n = 29
p-value
Age (years)a 74.4 ± 5.62 65.8 ± 9.92 0.002
Sex: male (%) 14 (88) 19 (66) 0.16
Location
Head 10 15 0.54
Body, tail 6 14
IPMN lesion type 




Pancreaticoduodenectomy 10 17 0.99
Distal pancreatectomy 6 10
Total pancreatectomy 0 1
Partial pancreatectomy 0 1
Pathological size (mm)a, b 50.4 ± 27.5 35.6 ± 21.5 0.03
aAge and pathological size are presented as mean ± standard deviation. bPathological size was determined as the longest dimension. IPMN – intraductal papillary mucinous neoplasm of the 
pancreas, MPD – main pancreatic duct
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method. Reader 2 was blinded to the results of Reader 1 
and the clinical and histopathological information.
Statistical analysis
The Mann-Whitney U and Fisher’s exact tests were used 
to compare continuous and binary variables, respective-
ly. All continuous variables measured by Reader 1 were 
used for statistical assessment of 2D and 3D analyses. All 
continuous variables measured by Reader 2 were used 
for inter-rater reliability assessment. The diagnostic per-
formances of continuous variables were estimated us-
ing receiver operating characteristic (ROC) curves and 
evaluated by comparing the area under the ROC curve 
(AUC), considering histopathological examination as 
the reference standard. Inter-rater reliability was as-
sessed using intraclass correlation coefficients (ICCs). 
ICCs of 0.81-1.0, 0.61-0.80, 0.41-0.60, 0.21-0.40, and 
≤ 0.20 represented almost perfect, substantial, moderate, 
fair, and slight agreement, respectively. Multivariate lo-
gistic regression analysis was performed with continuous 
variables of 2D and 3D analyses to determine the inde-
pendent predictors of IPMNs with high-grade dysplasia. 
Continuous variables that showed significant associa-
tion with IPMNs with high-grade dysplasia in univariate 
analysis and had almost perfect or substantial agreement 
in the inter-rater reliability assessment were included in 
the multivariate logistic regression analysis. Diagnostic 
accuracy was calculated based on cut-off values chosen 
to maximize the Youden index on the ROC analysis and 
assessed for the continuous variables in the multivariate 
analysis. A p-value of < 0.05 was considered statistically 
significant. All statistical analyses were performed us-
ing R software (The R Project for Statistical Computing, 
www.r-project.org, version 3.3.0) and SPSS (ver. 25; IBM 
Corp., Armonk, NY).
Results
The participant selection process is depicted in Figure 3. 
This study included 45 patients with histopathologically 
confirmed IPMNs with high- (n = 16) or low-grade dys-
plasia (n = 29) (Figures 4 and 5). Compared with patients 
with IPMNs with low-grade dysplasia, those with high-
grade dysplasia were older and had larger tumours as 
determined by the largest tumour diameter (p < 0.05; 
Table 1). Among MRI features, only an abrupt calibre 
change in MPD was significantly associated with IPMNs 
with high-grade dysplasia in univariate analysis (p < 0.05; 
Table 2). The results of 2D and 3D analyses are shown 
in Table 3. Box and whisker plots of 2D and 3D analy-
ses are shown in Figure 6. The ROIs of the 2D analysis 
Figure 1. Example of 2D analysis method. Sample of 1.5-Tesla magnetic resonance images of a 76-year-old man with branch-type intraductal papillary 
mucinous neoplasm of the pancreas (IPMN) with high-grade dysplasia in the head of the pancreas. A) Half-Fourier acquisition single-shot turbo spin-echo 
(HASTE) image. B-C) Diffusion-weighted (DW) image. D) Apparent diffusion coefficient (ADC) map. Mural nodule was identified in the branch-type IPMN 
on HASTE images (A). First, ROI in the spinal cord on DWI was located on a slice of the lumbar enlargement (B). Then, ROIs of the same size were set at the 
same location as that of the pancreatic lesion on each DW image and ADC map (C, D). Finally, the maximum signal intensity of the spinal cord on DWI, the 
highest mean signal intensity of the lesion on DWI, the lowest ADCmin, and the lowest ADCmean among the 3 measurements were adopted for analyses. Area 
of ROI, LSR, ADCmin, and ADCmean were 52 (mm




Takao Igarashi, Megumi Shiraishi, Ken Watanabe et al.  
e302 © Pol J Radiol 2021; 86: e298-e308
Figure 2. Example of 3D analysis method. Sample of 1.5-Tesla magnetic resonance images of a 79-year-old man with branch-type intraductal papillary 
mucinous neoplasm of the pancreas (IPMN) with high-grade dysplasia in the head of the pancreas. A 3D-VOI was placed on the area diagnosed as a mass 
with solid components on the apparent diffusion coefficient (ADC) map (areas marked in pink). All slices in which visible areas with measurable ADC values 
within the lesion occurred, were included. The ADC values were then constructed into a histogram as follows: Median ADC value = 3.08 (× 10-3 mm2/s), 
voxel count = 390, volume = 8.55 cm3.
(p = 0.97) and the VOIs of the 3D analysis (p = 0.46) 
were not significantly different. The LSR (mean value ± 
standard deviation) was 0.3 ± 0.1 for IPMNs with high-
grade dysplasia and 0.23 ± 0.09 for IPMNs with low-
grade dysplasia (AUC: 72%; p < 0.05). ADCoverall mean, AD-
Cmean0-10, ADCmean10-25, ADCmean25-50, and ADCentropy showed 
significant between-group differences (AUC = 72-93%; 
p < 0.05). Inter-rater reliability analysis showed almost 
perfect agreement for LSR and VOIs, and substantial 
agreement for ADCoverall mean and ADCentropy (Table 4). 
Multivariate logistic regression analysis showed that 
ADCoverall mean and ADCentropy were significant independent 
predictors of IPMNs with high-grade dysplasia (Table 5). 
The diagnostic accuracies of ADCoverall mean and ADCentropy 
were 80% and 73%, respectively (Table 5).
Discussion
The results of this study showed that ADCoverall mean and 
ADCentropy were significant independent predictors of 
IPMNs with high-grade dysplasia. Because none of the 
patients with IPMNs underwent FNA prior to MRI and 
surgery, all surgeries were performed considering the 
possibility of malignant potential. Patients with low-
grade dysplasia presented more enhancing mural nod-
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with low-grade dysplasia in clinical practice. Conse-
quently, enhancing mural nodules showed no significant 
association with IPMNs with high- and low-grade dys-
plasia in our univariate analysis. However, only abrupt 
calibre change in MPD was significantly associated with 
IPMNs with high-grade dysplasia. Our results indicated 
that differentiating IPMNs with high-grade dysplasia 
from those with low-grade dysplasia by analysing MRI 
features, based on the 2017 revised guidelines, might be 
difficult [21].
Traditionally, 2D analysis is performed using a value 
from within a manually set ROI on a single-slice image 
[10,13]. Theoretically, the most viable malignancy com-
ponent can be located anywhere within the lesion; thus, 
2D analysis is prone to subjective evaluation of lesion 
heterogeneity. Therefore, the inter-rater reliability for 2D 
analysis in this study showed fair agreement in all areas 
except for LSR. ADC value measurements in this study 
depended on the site chosen for setting the ROIs, which 
is highly reader-dependent and can cause reproducibility 
issues. Moreover, intralesional haemorrhage and fibrosis 
may manifest as blacked-out areas on T2-weighted im-
ages, which decreases the ADC value, irrespective of the 
presence of true restricted diffusion [17]. Conversely, LSR 
showed significant between-group differences and almost 
Figure 3. Flow diagram of the patient selection process. IPMN – intraductal 
papillary mucinous neoplasm of the pancreas, MR – magnetic resonance, 
CT – computed tomography, EUS – endoscopic ultrasonography
Patients who were diagnosed as IPMN of the pancreas with a maximum 
diameter of ≥ 1 cm upon histopathological examination after surgery between 
01/Jun/2009 and 30/Sep/2019 
Patients who underwent MR imaging before surgery 
Patients who underwent dynamic CT and/or EUS within 6 months  
before surgery, n = 80 
Patients who had coincidence  
of IPMN with a maximum diameter  
of < 1 cm which was not the purpose  
of surgery, n = 5 
Patients who were histopathologically  
diagnosed as IPMN with invasive  
carcinoma, n = 24 
Patients who did not undergo MR imaging 
within 6 months before surgery, n = 6 
IPMN with low-grade dysplasia, 
n = 29 
IPMN with high-grade dysplasia, 
n = 16
Figure 4. Sample of 3.0-Tesla magnetic resonance images in a 63-year-old woman with branch-type intraductal papillary mucinous neoplasm of the 
pancreas (IPMN) with low-grade dysplasia in the body of the pancreas. A – Maximum intensity projection image showing cystic lesion with lobulated 
shape and multi-septal structures (arrow). B – T2-weighted turbo spin echo image showing cystic lesion with a mural nodule (≥ 5 mm; arrowhead). 
C – Diffusion-weighted image showing no obvious high signal intensity (arrow). D – No definite restricted region was detected on the apparent diffusion 
coefficient (ADC) map (arrow). ADCoverall mean and ADCentropy were 3.16 and 3.05 (× 10
-3 mm2/s), respectively
Eligible for this study 
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perfect inter-rater agreement. Therefore, the use of LSR to 
detect suspicious lesions on an ADC map could contrib-
ute to improved lesion assessment. Considering the major 
guidelines, which recommend FNA prior to resection for 
determining the presence of suspicious or positive cytol-
ogy [21,23,24], identification of the most suspicious solid 
component of IPMNs is a prerequisite for selecting the 
appropriate FNA sampling site. LSR may act as a guide for 
FNA by identifying the suspicious site for targeted biopsy, 
enabling endoscopists to determine the sampling site with 
greater confidence. 
We considered that the lower AUCs for ADCmin and 
ADCmean than for LSR in 2D analysis were related to the 
overlap in ADC values between IPMNs with high- and 
low-grade dysplasia, as previously reported by Kang et al. 
[10]. Therefore, it is difficult to differentiate IPMNs with 
Figure 5. Sample of 1.5-Tesla magnetic resonance images in a 76-year-old man with non-invasive intraductal papillary mucinous neoplasm of the pancreas 
(IPMN) with high-grade dysplasia in the tail of the pancreas. A – Maximum intensity projection image showing cystic lesion with multi-septal structures 
(arrow). B – T2-weighted turbo spin echo image showing cystic lesion with a mural nodule (arrowhead). C – Diffusion-weighted image showing a high 
signal lesion (arrow). D – A partially low signal region was detected on the apparent diffusion coefficient (ADC) map, suggestive of restricted diffusion 
(arrow). ADCoverall mean and ADCentropy were 1.88 (× 10




Table 2. Magnetic resonance imaging features of patients with intraductal papillary mucinous neoplasm of the pancreas (IPMNs) with high- and with low-
grade dysplasia with reference to the revised International Consensus Guidelines for the Management of IPMN of the Pancreas, 2017
Factor IPMNs with high-grade dysplasia 
n = 16a




Enhancing mural nodule ≥ 5 mm 13 (81) 17 (59) 0.19
MPD size ≥ 10 mm 6 (38) 4 (14) 0.13
Worrisome features
Cyst size ≥ 3 cm 8 (50) 17 (59) 0.76
Enhancing mural nodule < 5 mm 0 0 > 0.99
Thickened enhancing cyst wall 9 (56) 17 (59) > 0.99
MPD size 5-9 mm 3 (19) 6 (21) > 0.99
Abrupt MPD calibre change 6 (38) 1 (11) 0.005
Lymphadenopathy 0 0 > 0.99
aNumbers in parentheses represent percentages. MPD – main pancreatic duct
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Table 3. Comparison of the area under the receiver operating characteristic curve between IPMNs with high- and low-grade dysplasia 
IPMNs with high-grade dysplasia
n = 16
IPMNs with low-grade dysplasia
n = 29
AUC 95% CI p-value
Ave SD Ave SD Lower limit Upper limit
2D analysisa
ROI (mm2) 53.81 11.15 53.93 13.99 0.50 0.33 0.68 0.97
LSR 0.30 0.10 0.23 0.09 0.72 0.56 0.88 0.01
ADCmin 1674.69 480.35 1728.30 843.04 0.60 0.43 0.77 0.25
ADCmean 1989.06 588.52 2225.10 1010.67 0.64 0.47 0.81 0.10
3D analysisa
VOI (cm3) 20.99 29.01 15.17 28.01 0.57 0.39 0.74 0.46
ADCoverall mean 2394.93 351.72 2859.04 402.10 0.81 0.68 0.95 < 0.05
ADCmean0–10 1561.66 354.26 2319.24 345.63 0.93 0.86 1.01 < 0.05
ADCmean10–25 1793.10 346.31 2469.09 342.34 0.91 0.81 1.00 < 0.05
ADCmean25–50 2163.44 345.15 2709.03 368.73 0.85 0.73 0.97 < 0.05
ADCskewness –0.35 0.36 –0.06 0.67 0.63 0.47 0.80 0.11
ADCkurtosis –0.000048 0.88 0.11 0.75 0.58 0.39 0.77 0.40
ADCentropy 4.11 0.18 3.85 0.44 0.72 0.56 0.87 0.01
aADCmin, ADCmean, ADCoverall mean, ADCmean0-10, ADCmean10-25, ADCmean25-50 (× 10
-6 mm2/s). IPMN – intraductal papillary mucinous neoplasm of the pancreas, Ave – average, SD – standard deviation, AUC 
– area under the curve, CI – confidence interval, ROI – region of interest, LSR – lesion-to-spinal cord signal intensity ratio, ADC – apparent diffusion coefficient, VOI – volume of interest
Table 4. Results of inter-rater reliability assessment
Parameter Intraclass correlation 
coefficient
95% CI Degree of agreement
Lower limit Upper limit
2D analysis ROI 0.259 –0.034 0.511 Fair
LSR 0.898 0.822 0.943 Almost perfect
ADCmin 0.339 0.053 0.573 Fair
ADCmean 0.379 0.099 0.603 Fair
3D analysis VOI 0.832 0.714 0.904 Almost perfect
ADCoverall mean 0.697 0.509 0.821 Substantial
ADCmean0-10 0.399 0.123 0.618 Fair
ADCmean10-25 0.219 –0.077 0.479 Fair
ADCmean25-50 0.563 0.326 0.734 Moderate
ADCskewness 0.153 –0.144 0.425 Slight
ADCkurtosis 0.361 0.079 0.59 Fair
ADCentropy 0.744 0.579 0.851 Substantial
CI – confidence interval, ROI – region of interest, LSR – lesion-to-spinal cord signal intensity ratio, ADC – apparent diffusion coefficient, VOI – volume of interest
Table 5. Results of multivariate logistic regression analysis and comparison of diagnostic performance of continuous variables in predicting intraductal 
papillary mucinous neoplasm of the pancreas with high-grade dysplasia
Parameter Multivariate analysis Cut-off 
value
Diagnostic performance
OR 95% CI p-value Sensitivity Specificity PPV NPV Accuracy
2D analysis
LSR 3.26 0.52–20.37 0.21 0.25 69 69 55 80 69
3D analysis
ADCoverall mean 23.19 2.42–222.64 < 0.05 2.48a 75 83 71 86 80
ADCentropy 20.77 2.11–204.30 < 0.05 4.04 81 69 59 87 73
IPMN – intraductal papillary mucinous neoplasm of the pancreas, LSR – lesion-to-spinal cord signal intensity ratio, ADC – apparent diffusion coefficient, PPV – positive predictive value, 
NPV – negative predictive values. All data for diagnostic performance, except for cut-off values, are expressed as percentages. aADC (× 10-3 mm2/s)
Takao Igarashi, Megumi Shiraishi, Ken Watanabe et al.  
e306 © Pol J Radiol 2021; 86: e298-e308
high-grade dysplasia from those with low-grade dysplasia 
using ADCmin and ADCmean values obtained by 2D analy-
sis, because both lesion types presumably have histopath-
ologically similar internal structures. 
However, VOIs in 3D analysis showed almost per-
fect inter-rater agreement, which was expected because 
3D analysis is considered to be an objective method for 
highly reproducible evaluation of lesion heterogeneity. 
Among the 3D analysis parameters, ADCoverall mean and 
ADCentropy showed significant between-group differences 
in univariate analysis and substantial inter-rater agree-
ment. Multivariate analysis showed that ADCoverall mean and 
ADCentropy were independent predictors of IPMNs with 
high-grade dysplasia. Malignant tumours tend to appear 
as heterogeneous tissue, resulting in unpredictable inten-
sity characteristics within the tissue. Entropy is a mea-
sure of uncertainty and randomness in image values [22]. 
IPMNs with high-grade dysplasia have a more irregular 
epithelial growth pattern and a disorganized polarity than 
those with low-grade dysplasia [3]. In this study, higher 
ADCentropy was seemingly caused by this histopathologi-
cal phenomenon. Hoffman et al. recently reported that 
ADCentropy of 3D whole-lesion histogram metrics was 
a significant factor for differentiating benign and ma-
lignant branch-type IPMNs [20]. However, the AUC for 
ADCentropy in the present study was not as high as that re-
ported by Hoffman et al. [20], probably because of dif-
ferences in the applied b-value [25]. In their study, DWI 
was performed with a high b-value of 500 s/mm2 [20], 
whereas our high b-value was 800 s/mm2. Moreover, the 
DWI matrix in their protocol (128-144 × 192) was larger 
than the one we used for 1.5-T MRI (77 × 128). There-
Figure 6. Box-and-whisker plots comparing quantitative variables obtained from 2D and 3D analyses of intraductal papillary mucinous neoplasm 
of the pancreas (IPMN) with low- and high-grade dysplasia. Circles indicate outliers. Medians (line through boxes) for apparent diffusion coefficient 
(ADC) – ADCoverall mean, ADCmean0–10, ADCmean10–25, ADCmean25–50 were lower in IPMNs with high-grade dysplasia than those in IPMNs with low-grade dysplasia. 
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fore, the irregularity of the intra-lesion voxel distribution 
could be indistinct, and the possible increased overlap of 
ADCentropy between IPMNs with high-grade dysplasia and 
IPMNs with low-grade dysplasia might have confounded 
our results. These factors may have contributed to our 
lower AUC for ADCentropy. Further studies are needed to 
investigate the role of ADCentropy based on standardized 
MRI protocols.
This study had several limitations. First, this was a ret-
rospective, single-centre study with a limited number of 
patients. Additional studies with large cohorts are needed 
to further investigate the technique utilized in this study. 
Second, clinical variables and cyst growth rates > 5 mm/ 
2 years, included as evaluation points in the revised 2017 
guidelines, were not evaluated. Third, 3T-MRI has a great-
er magnetic susceptibility effect than does 1.5T-MRI. This 
increases the possibility of image distortion. Therefore, if 
lesions with hemosiderin deposition and the resultant 
susceptibility effect are present, magnetic susceptibility 
may affect 3D analysis. Fourth, we used ADC values with 
b-values of 50 and 800 s/mm2, generated from a mono-
exponential model (conventional DWI). Theoretically, 
this method is influenced by perfusion and diffusion ef-
fects. Intravoxel incoherent motion (IVIM)-DWI, which 
is based on a bi-exponential model with multiple b-value 
combinations, and which can separate perfusion and dif-
fusion effects, may therefore be more valuable because it 
can provide more accurate data about signal decay, em-
phasizing perfusion or diffusion effects [26]. Further stud-
ies using IVIM-DWI are needed to investigate its poten-
tial as a quantitative biomarker for predicting malignant 
IPMNs.
Conclusions
The present results suggest that combining the ADCoverall 
mean and ADCentropy values from 3D analysis and LSR from 
2D analysis may assist in predicting IPMNs with high-
grade dysplasia. Assessment of ADCoverall mean and ADCen-
tropy from 3D analysis could help to identify patients with 
IPMNs with high-grade dysplasia using non-enhanced 
MRI techniques.
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